Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × FED × Plasma cell × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

OTHER 695 INDUSTRY 177 NIH 87 NETWORK 39 OTHER_GOV 4 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 18 Thoracic 4 Other hematologic neoplasm 4 Lymphoid 4 Gastrointestinal 3 Dermatologic 2 CNS 2 Tumor-Agnostic 1 Plasma cell 1 Myeloid 1 Head & Neck 1 Breast 1

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia 1

Interventions

Topotecan 1 Mitoxantrone 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00100477 2013-09-25

Use of Topotecan in Patients With Refractory Acute Leukemia

VA Office of Research and Development

Phase 2 Completed

LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡